Circio Holding ASA Logo

Circio Holding ASA

CRNA | XOSL

Overview

Corporate Details

ISIN(s):
NO0012858564 (+5 more)
LEI:
5967007LIEEXZXFYNS31
Country:
Norway
Address:
Vollsveien 19, 1366 Lysaker
Sector:
Health Care
Industry:
Biotechnology

Description

Circio Holding ASA (OSE: CRNA) is a biotechnology company developing novel circular RNA and immunotherapy medicines. Circio Holding ASA is a biotechnology company developing novel circular RNA and immunotherapy medicines. Circio has established a unique circular RNA (circRNA) platform to develop novel circRNA medicines for rare disease, vaccines, and cancer. The proprietary circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA and viral vectors, which can be deployed for many purposes. The circVec platform has demonstrated enhanced and more durable protein expression than classic mRNA vector systems, and has the potential to become the new gold-standard for DNA and virus-based therapeutics in the future. The circRNA R&D activities are being conducted by the wholly owned subsidiary Circio AB based at the Karolinska Institute in Stockholm, Sweden.

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-06 09:53
Capital/Financing Update
Circio Holding ASA: Registration of share capital increase following conversion…
English 2.7 KB
2025-06-05 13:49
Declaration of Voting Results & Voting Rights Announcements
Circio Holding ASA: Minutes from the annual general meeting 2025 - Attachment: …
English 870.6 KB
2025-06-05 13:49
Declaration of Voting Results & Voting Rights Announcements
Circio Holding ASA: Minutes from the annual general meeting 2025
English 2.9 KB
2025-06-04 22:00
Capital/Financing Update
Circio Holding ASA: Requested Conversion of Convertible Bonds
English 3.5 KB
2025-05-28 07:00
Investor Presentation
Circio presents new and differentiating circVec data and corporate update in li…
English 2.7 MB
2025-05-28 07:00
Regulatory News Service
Circio presents new and differentiating circVec data and corporate update in li…
English 6.0 KB
2025-05-27 15:35
Proxy Solicitation & Information Statements
Circio Holding ASA - Updated information to the notice of annual general meetin…
English 120.7 KB
2025-05-27 15:35
Share Issue/Capital Change
Circio Holding ASA - Updated information to the notice of annual general meetin…
English 4.2 KB
2025-05-22 05:00
Report Publication Announcement
Circio invites to R&D and corporate update webcast on 28 May 2025
English 2.2 KB
2025-05-15 13:30
Regulatory News Service
Circio Holding ASA - Notice of annual general meeting 2025
Norwegian 1.6 MB
2025-05-15 13:30
Regulatory News Service
Circio Holding ASA - Notice of annual general meeting 2025
Norwegian 2.7 KB
2025-05-15 10:19
Capital/Financing Update
Circio Holding ASA: Registration of share capital increase following conversion…
English 2.7 KB
2025-05-15 06:07
Major Shareholding Notification
Atlas Holdings for CIRCIO
English 760 bytes
2025-05-14 06:11
Major Shareholding Notification
Atlas Holdings for CIRCIO
English 732 bytes
2025-05-13 23:00
Inside Information Statement
Circular RNA innovator Circio presents strengthened circVec gene therapy data a…
English 1.9 MB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC